Walleye Trading »

Atrium Therapeutics shares owned by Walleye Trading

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Walleye Trading from 13F filings

Historical chart of Walleye Trading investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Walleye Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Walleye Trading

Quarter filed Position value Share count Share price at filing
2026-03-31 $407k 30k 13.37

More positions owned by Walleye Trading

Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
UnitedHealth Call Option (UNH)
Intel Corporation (INTC)
Micron Technology (MU)
Broadcom Call Option (AVGO)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Amazon (AMZN)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)

View all positions for Walleye Trading

Top funds holding Atrium Therapeutics

BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation
Weiss Asset Management LP[1

View all funds holding Atrium Therapeutics